Skip To Main Content
John Harty on Muck Rack

John Harty

As seen in: Nature, PNAS, Science Magazine, Business Report, Cape Argus, Cell Reports, Cell Press, S&P Global, Bristol Herald Courier, The Journal of Immunology and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with John

Contact John, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Longitudinal analysis reveals myeloid cell contributions to murine neuroPASC pathogenesis

|
By Lu Tan, ABHISHEK VERMA, Shea Lowery, Andrew Thurman, Alan Sariol, Cori E. Fain, Zhaoyuan Liu, Florent Ginhoux, John Harty, David Meyerholz, Stanley Perlman
| Nature Verified
Abstract Neurological and neuropsychiatric symptoms, collectively termed neuroPASC, are among the most prevalent Post-Acute Sequelae of COVID-19 (PASC). Neuroinflammation – particularly microglia reactivity – has been implicated in neuroPASC. We previously established a PASC model in which SARS-CoV-2-infected mice developed persistent behavior alterations and prolonged neuroinflammation for up to 120 days post-infection (dpi).
Open in Who Shared Issue with article?

The endemic dilemma: why whole sporozoite malaria vaccine efficacy falls in the field

|
By Mariah Hassert, John Harty
| Cell Press Verified
Keywords liver stage Plasmodium infection Plasmodium whole sporozoite vaccines The WSV efficacy gap While significant strides have been made in the areas of vaccination, chemoprophylaxis, and vector control, infections by Plasmodium are still responsible for more than 200 million cases and 600 000 deaths annually [1]. A number of candidates have made it to the forefront as potential vaccines to curb the spread of this devastating disease [2,3].
Open in Who Shared Issue with article?

TH1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata

|
By Gautier Hamon, Alain Rios, Xiaohui Zhong, Samuel Connell, Sydney Crotts, Ryan Reis, Maddison Lensing, Nicholas Henderson, Otgonzaya Ayush, Zhaowen Zhu, Luana S. Ortolan, Audrey Ko, Erin Shriver, Keith Carter, John Harty, Joan Goverman, Ali Jabbari, Payton Kahl
| Science Magazine Verified
Abstract Alopecia areata (AA) is an autoimmune disease defined by hair loss and peribulbar infiltrate of CD8 and CD4 T cells. Prior studies have focused on the role of CD8 T cells in the development of AA. Multiple roles for CD4 T cell help have been demonstrated for support of CD8 T cell responses; however, the role of CD4 T cells in AA remains unclear. Here, we demonstrate that CD4 T cells from the skin-draining lymph nodes (SDLNs) of AA mice transferred disease to recipient mice.
Open in Who Shared Issue with article?
See all 24 articles